HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon
- PMID: 9487410
HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon
Abstract
To determine the HIV seroprevalence in adult patients with pulmonary tuberculosis in Yaounde and to compare the incidence of adverse skin reactions in patients with and without HIV infection receiving thiacetazone-free antituberculosis treatment, we studied 235 consecutive patients aged 15 years or more admitted into the Chest Clinic of Hospital Jamot in Yaounde with a diagnosis of pulmonary tuberculosis from July 1 to December 31, 1994. HIV testing was done using two ELISAs and confirmed by Western blot. Each patient was monitored for adverse skin reactions to antituberculosis treatment during the two month initial phase of therapy in hospital. Of the 235 patients studied, 156 (66%) were males (mean age: 33 years) and 79 were females (mean age: 30.3 years). Overall, 16.6% (39 cases) of the 235 patients were HIV seropositive. The prevalence of HIV infection was significantly higher in women (24%) than in men (12.5%) (p = 0.02). Adverse skin reactions to antituberculosis treatment were observed in eleven (4.7%) of the 235 patients. The incidence of the reactions was significantly higher in HIV seropositive (23.1%) than in HIV seronegative patients (1.0%) (p < 10 - 7). Two HIV seropositive patients who developed Stevens-Johnson syndrome died. The drugs incriminated for adverse skin reactions in the nine patients who survived were pyrazinamide (four cases) and rifampicin (five cases).
PIP: A prospective study of 235 consecutive pulmonary tuberculosis (TB) patients admitted to Hospital Jamot in Yaounde, Cameroon, in a 6-month period in 1994 investigated the HIV seroprevalence in these patients and compared the incidence of adverse skin reactions in HIV-positive and HIV-negative patients receiving thiacetazone-free anti-TB treatment. Mean age was 33.0 years in the 158 male and 30.3 years in the 79 female patients. A total of 39 patients (16.6%) were HIV-seropositive; the seroprevalence rate was significantly higher in women (24.0%) than men (12.5%). Adverse skin reactions to anti-TB treatment were noted in 11 patients (4.7%) within 2-8 weeks of onset of treatment. Such reactions occurred in 9 (23.1%) of the HIV-positive patients compared with only 2 (1.0%) seronegative patients. The 2 patients (both HIV-positive) who developed Stevens-Johnson syndrome died. In the remaining 9 cases, reactions were mild to moderate and resolved with discontinuation of treatment (pyrazinamide or rifampicin) with or without the administration of symptomatic treatment. The World Health Organization has warned against use of thiacetazone in the treatment of TB in HIV-infected patients given the high frequency of sometimes fatal cutaneous hypersensitivity reactions. The findings of the present study indicate that, even when thiacetazone-free drugs are used, HIV-infected TB patients should be monitored carefully for adverse skin reactions.
Similar articles
-
Current HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone-free antituberculosis treatment in Yaounde, Cameroon.Cent Afr J Med. 1998 Feb;44(2):34-7. Cent Afr J Med. 1998. PMID: 9675969
-
Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania.Trop Geogr Med. 1992 Oct;44(4):308-11. Trop Geogr Med. 1992. PMID: 1284179
-
Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults.Int J Tuberc Lung Dis. 1997 Oct;1(5):441-5. Int J Tuberc Lung Dis. 1997. PMID: 9441099 Clinical Trial.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
[Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].Kekkaku. 2003 Nov;78(11):683-9. Kekkaku. 2003. PMID: 14672045 Review. Japanese.
Cited by
-
Risk of Complications in HIV-TB Co-Infection: A Hospital-Based Pair-Matched Case-Control Study.Indian J Community Med. 2010 Oct;35(4):506-8. doi: 10.4103/0970-0218.74361. Indian J Community Med. 2010. PMID: 21278872 Free PMC article. No abstract available.
-
Characteristics of patients co-infected with HIV at the time of inpatient tuberculosis treatment initiation in Yaoundé, Cameroon: a tertiary care hospital-based cross-sectional study.Arch Public Health. 2015 May 4;73(1):24. doi: 10.1186/s13690-015-0075-y. eCollection 2015. Arch Public Health. 2015. PMID: 25941570 Free PMC article.
-
HIV testing, HIV status and outcomes of treatment for tuberculosis in a major diagnosis and treatment centre in Yaounde, Cameroon: a retrospective cohort study.BMC Infect Dis. 2012 Aug 15;12:190. doi: 10.1186/1471-2334-12-190. BMC Infect Dis. 2012. PMID: 22894713 Free PMC article.
-
Update on the management of antibiotic allergy.Allergy Asthma Immunol Res. 2010 Apr;2(2):77-86. doi: 10.4168/aair.2010.2.2.77. Epub 2010 Mar 24. Allergy Asthma Immunol Res. 2010. PMID: 20358021 Free PMC article.
-
Clinical applications of drug desensitization in the Asia-Pacific region.Asia Pac Allergy. 2011 Apr;1(1):2-11. doi: 10.5415/apallergy.2011.1.1.2. Epub 2011 Apr 26. Asia Pac Allergy. 2011. PMID: 22053290 Free PMC article.